383 related articles for article (PubMed ID: 37607734)
1. Emerging and potential use of CRISPR in human liver disease.
Adlat S; Vázquez Salgado AM; Lee M; Yin D; Wangensteen KJ
Hepatology; 2023 Aug; ():. PubMed ID: 37607734
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Genome Editing Partially Restores Alpha1-Antitrypsin in a Murine Model of AAT Deficiency.
Song CQ; Wang D; Jiang T; O'Connor K; Tang Q; Cai L; Li X; Weng Z; Yin H; Gao G; Mueller C; Flotte TR; Xue W
Hum Gene Ther; 2018 Aug; 29(8):853-860. PubMed ID: 29597895
[TBL] [Abstract][Full Text] [Related]
3. The Application of the CRISPR/Cas9 System in the Treatment of Hepatitis B Liver Cancer.
Lv W; Li T; Wang S; Wang H; Li X; Zhang S; Wang L; Xu Y; Wei W
Technol Cancer Res Treat; 2021; 20():15330338211045206. PubMed ID: 34605326
[TBL] [Abstract][Full Text] [Related]
4. Toward In Vivo Gene Therapy Using CRISPR.
Skipper KA; Mikkelsen JG
Methods Mol Biol; 2019; 1961():293-306. PubMed ID: 30912053
[TBL] [Abstract][Full Text] [Related]
5. mRNA and gene editing: Late breaking therapies in liver diseases.
Zabaleta N; Torella L; Weber ND; Gonzalez-Aseguinolaza G
Hepatology; 2022 Sep; 76(3):869-887. PubMed ID: 35243655
[TBL] [Abstract][Full Text] [Related]
6. Applications of CRISPR for musculoskeletal research.
Fitzgerald J
Bone Joint Res; 2020 Jul; 9(7):351-359. PubMed ID: 32676188
[TBL] [Abstract][Full Text] [Related]
7. Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies.
McTague A; Rossignoli G; Ferrini A; Barral S; Kurian MA
Front Genome Ed; 2021; 3():630600. PubMed ID: 34713254
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas gene therapy.
Zhang B
J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
[TBL] [Abstract][Full Text] [Related]
9. CRISPR and cardiovascular diseases.
Musunuru K
Cardiovasc Res; 2023 Mar; 119(1):79-93. PubMed ID: 35388882
[TBL] [Abstract][Full Text] [Related]
10. Gene Editing in Clinical Practice: Where are We?
Mittal RD
Indian J Clin Biochem; 2019 Jan; 34(1):19-25. PubMed ID: 30728669
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic Mice.
Shen S; Sanchez ME; Blomenkamp K; Corcoran EM; Marco E; Yudkoff CJ; Jiang H; Teckman JH; Bumcrot D; Albright CF
Hum Gene Ther; 2018 Aug; 29(8):861-873. PubMed ID: 29641323
[TBL] [Abstract][Full Text] [Related]
12. Cas9-nickase-mediated genome editing corrects hereditary tyrosinemia in rats.
Shao Y; Wang L; Guo N; Wang S; Yang L; Li Y; Wang M; Yin S; Han H; Zeng L; Zhang L; Hui L; Ding Q; Zhang J; Geng H; Liu M; Li D
J Biol Chem; 2018 May; 293(18):6883-6892. PubMed ID: 29507093
[TBL] [Abstract][Full Text] [Related]
13. CRISPR Technology in Cancer Diagnosis and Treatment: Opportunities and Challenges.
Shademan B; Masjedi S; Karamad V; Isazadeh A; Sogutlu F; Rad MHS; Nourazarian A
Biochem Genet; 2022 Oct; 60(5):1446-1470. PubMed ID: 35092559
[TBL] [Abstract][Full Text] [Related]
14. Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer.
Meng H; Nan M; Li Y; Ding Y; Yin Y; Zhang M
Front Endocrinol (Lausanne); 2023; 14():1148412. PubMed ID: 37020597
[TBL] [Abstract][Full Text] [Related]
15. [Application of genome editing technology in gene therapy].
Hiramoto T; Ohmori T
Rinsho Ketsueki; 2022; 63(11):1558-1565. PubMed ID: 36476798
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic editing of hepatocyte genome in vivo.
Ruiz de Galarreta M; Lujambio A
J Hepatol; 2017 Oct; 67(4):818-828. PubMed ID: 28527665
[TBL] [Abstract][Full Text] [Related]
17. Novel vectors and approaches for gene therapy in liver diseases.
Maestro S; Weber ND; Zabaleta N; Aldabe R; Gonzalez-Aseguinolaza G
JHEP Rep; 2021 Aug; 3(4):100300. PubMed ID: 34159305
[TBL] [Abstract][Full Text] [Related]
18. Prime Editing for Human Gene Therapy: Where Are We Now?
Godbout K; Tremblay JP
Cells; 2023 Feb; 12(4):. PubMed ID: 36831203
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
[TBL] [Abstract][Full Text] [Related]
20. Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus.
Moyo B; Bloom K; Scott T; Ely A; Arbuthnot P
Virus Res; 2018 Jan; 244():311-320. PubMed ID: 28087399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
